Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases

Invention Grant

US09320811B2 Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases 有权

Title translation: 抗CTLA4抗体与多种治疗方案的组合，用于增殖性疾病的协同治疗

Patent Title: Combination of anti-CTLA4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
Patent Title (中): 抗CTLA4抗体与多种治疗方案的组合，用于增殖性疾病的协同治疗
Application No.: US14168465

Application Date: 2014-01-30
Publication No.: US09320811B2

Publication Date: 2016-04-26
Inventor: Maria Jure-Kunkel
Applicant: Bristol-Myers Squibb Company
Applicant Address: US NJ Princeton
Assignee: Bristol-Myers Squibb Company
Current Assignee: Bristol-Myers Squibb Company
Current Assignee Address: US NJ Princeton
Agent Stephen C. D'Amico
Main IPC: A61K47/48
IPC: A61K47/48 ; A61K31/505 ; A61K39/395 ; A61K45/06 ; A61K31/555 ; A61K31/7068 ; A61K33/24

Abstract:

Compositions and methods are disclosed which are useful of the treatment and prevention of proliferative disorders.

Abstract(Chinese):

公开了可用于治疗和预防增殖性疾病的组合物和方法。

Public/Granted literature

Information query

Espacenet